Cardiac 3D MRI in Pediatric Cancer Patients

Withdrawn before enrolling

Conditions studied: Childhood Cancer

In brief

This is a non-randomized prospective pilot study in a single academic center with historic controls. This study will compare Cardiac Magnetic Resonance Images (MRI) of patients who have undergone childhood cancer treatment that has cardio-toxic effects to historic controls. The ultimate goal of this study is to develop a safe and effective method for early diagnosis of heart problems in children who are receiving chemotherapy treatments that may be toxic to the heart.

Key facts

Study ID

NCT02130934

Run by

Majd Makhoul

People needed

0

Starts

2014-05-01

Expected to finish

2016-03-01

Last updated by the study team

2016-11-15

Who can join

Age: 8 and older, up to 26. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Childhood cancer treatment which has been completed
• Received anthracyclines as part of childhood cancer treatment, at least 150 mg/m2 as cumulative dose
• normal left ventricular systolic and diastolic functions on echocardiogram

You may not qualify if…

• Ongoing cancer treatment
• Pregnancy
• Inability to undergo a cardiac MRI
• Abnormal ventricular systolic or diastolic function on echocardiogram

Where it is running

• UK Medical Center — Lexington, Kentucky, United States
• University of Kentucky Medical Center — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.